CD8:PA:PA-Amundi ETF MSCI EMU High Dividend UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 172.06

Change

+1.20 (+0.70)%

Market Cap

USD 0.22B

Volume

2.76K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.61 (+1.30%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+0.80 (+0.14%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.07 (+0.02%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

+0.10 (+0.26%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+2.87 (+1.10%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+0.10 (+0.02%)

USD 8.85B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.10 (+0.31%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

+0.07 (+0.12%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.91B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.16 (-2.18%)

USD 5.25B

ETFs Containing CD8:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.21% 84% B 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.21% 84% B 76% C+
Trailing 12 Months  
Capital Gain 11.09% 49% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.09% 48% F 61% D-
Trailing 5 Years  
Capital Gain 46.43% 47% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 46.43% 45% F 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 10.47% 59% D- 64% D
Dividend Return 10.47% 56% F 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.57% 59% D- 78% C+
Risk Adjusted Return 90.49% 66% D+ 83% B
Market Capitalization 0.22B 45% F 57% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.